H
Herbal Dispatch Inc
CNSX:HERB
Herbal Dispatch Inc
CNSX:HERB
Price:
0.055
CAD
10%
Market Cap:
CA$6.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Herbal Dispatch Inc
CNSX:HERB
|
CA |
|
Sunstone Hotel Investors Inc
NYSE:SHO
|
US |
|
MiraeAsset Maps REIT 1 Co Ltd
KRX:357250
|
KR |
|
H
|
Hume Cement Industries Bhd
KLSE:HUMEIND
|
MY |
|
Princeton Capital Corp
OTC:PIAC
|
US |
|
Pentair PLC
NYSE:PNR
|
UK |
|
N
|
Norwegian Air Shuttle ASA
XBER:NWC
|
NO |
|
MCJ Co Ltd
TSE:6670
|
JP |
|
Saia Inc
NASDAQ:SAIA
|
US |
|
Ten Lifestyle Group PLC
LSE:TENG
|
UK |
|
Hoshizaki Corp
TSE:6465
|
JP |
|
A
|
Apex Equity Holdings Bhd
KLSE:APEX
|
MY |
|
Ypsomed Holding AG
SIX:YPSN
|
CH |
Relative Value
The Relative Value of one HERB stock under the Base Case scenario is hidden CAD. Compared to the current market price of 0.055 CAD, Herbal Dispatch Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HERB Relative Value
HIDDEN
Multiples Across Competitors
HERB Competitors Multiples
Herbal Dispatch Inc Competitors
Herbal Dispatch Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
H
|
Herbal Dispatch Inc
CNSX:HERB
|
6.8m CAD | 0.7 | -2.2 | -4.6 | -3.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.2 | 41.8 | 28.2 | 30.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.6 | 11.1 | 12.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.5B GBP | 4.9 | 28 | 15.6 | 21.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
221.8B CHF | 5.1 | 20.6 | 12.8 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.4 | 19.6 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
